Our Mission
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy.
Latest News
-
25 November 2024ISHLT2025 Supporter Opportunities Still Available
-
20 November 2024State of the art review on aortic insufficiency in durable LVADs on JHLT: The Podcast
-
18 November 2024November Journal Watch Explores Topics in Cardiothoracic Surgery
With more than 3,600 members worldwide across multiple disciplines, ISHLT is your professional society home, and thrives because of the unique contributions of each member.
Renew today for another year of community, growth, and scientific progress.
Renew Your Membership
ISHLTconnect is an online discussion platform open to anyone involved in the management and treatment of advanced heart and lung disease, transplantation, mechanical circulatory support, and pulmonary vascular disease. Members get complete access to all interdisciplinary discussion groups, while nonmembers can explore ten Professional Community boards.
Log InUpcoming Events
-
4 December, 2024 3:00 p.m. to 4:00 p.m. ESTISHLT/SCA Joint Webinar: The Borders of MCS-land
This one-hour joint webinar from the ISHLT Anesthesiology & Critical Care Professional Community and the Society of Cardiovascular Anesthesiologists (SCA) will cover basic insights in the anesthetic management during LVAD implantation. -
16 January to 19, 2025ASTS 2025 Winter Symposium
The Winter Symposium is a premier event dedicated to transplant surgery, hosted by the American Society of Transplant Surgeons (ASTS).Phoenix, AZ, USA -
2 February, 2025 2:00 p.m. to 3:00 p.m. ESTActive Inflammatory End-Stage Heart/Lung Diseases: To Do or Not to Do?
This session will explore the issues specific to patients with inflammatory pathologies requiring heart and/or lung transplantation. It will also examine the outcomes of these patients and the problems associated with native pathologies.
and Lung Transplantation
